Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Flexible On Data Sources, Techniques For Pediatric Device Claims

This article was originally published in The Gray Sheet

Executive Summary

Computer modeling, Bayesian hierarchal modeling and use of off-label data sources are among novel methodologies that the device center may accept to demonstrate device effectiveness in kids, officials said Dec. 5.

You may also be interested in...

Adaptive Trials Guidance For Pediatric Drugs Will Draw On Device Advice

FDA’s centers may slingshot development work on how best to use control data.

Regulatory News In Brief

FDA misses some performance goals. Device center issues ombudsman’s report. DePuy stops selling custom devices. More regulatory briefs.

FDA Withdraws Pediatric Data-Submission Rule, But Aims To Regroup Shortly

FDA has 1withdrawn a new regulation that would have required companies to submit additional pediatric patient data as part of pre-market submissions beginning next month, but says it hopes to finalize a possibly revised version soon





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts